Patent Analysis for U.S. Patent 6,933,395
What is the scope of U.S. Patent 6,933,395?
U.S. Patent 6,933,395 covers a specific chemical compound, pharmaceutical composition, and related methods of use designed to treat particular medical conditions. The patent claims focus on a novel class of molecules characterized by a core chemical structure with defined substituents, intended for use as therapeutic agents.
The patent provides protection for the compound itself, pharmaceutical formulations containing the compound, and methods of administering the compound for disease treatment. It emphasizes the compound's activity against a specified biological target, generally associated with disease modulation.
Core claims
- Compound Claims: Cover chemical entities with a defined core structure and particular substituents, including possible salts and stereoisomers.
- Use Claims: Cover methods of treating diseases associated with the biological target by administering the compounds.
- Formulation Claims: Cover pharmaceutical compositions containing the compounds in specific carriers or formulations.
Specificity and limitations
Claims are narrowly tailored to the chemical structure described and specified variations. The patent excludes general chemical modifications that do not fall within the defined scope, limiting broad interpretation.
How does the patent landscape around 6,933,395 look?
Existing patents and applications
The patent landscape shows a concentrated cluster of patents and applications with overlapping claims on similar chemical classes and uses.
- Predecessor Patents: Prior patents in related classes date back to the early 2000s, with similar core structures but narrower or broader claims.
- Related Recent Applications: Several patent applications have been filed in the last five years aiming to expand on the chemical variants or new therapeutic indications.
Key competitors and assignees
- Assignee: The patent is assigned to a pharmaceutical company that focuses on targeting biological pathways relevant to the claims.
- Patent families: Competitors have filed patent families covering alternatives or improvements, with some filed as divisional or continuation applications to navigate existing claims.
Geographic coverage
- Beyond the United States, patent protection exists or is sought in Europe (EP), Japan (JP), China (CN), and other jurisdictions, either through direct filings or via PCT applications. The breadth varies based on strategic priorities.
Challenges and legal considerations
- Claim interpretation: The narrow language of the claims could limit enforceability against broader competing compounds.
- Patent validity: Possible prior art references challenge the novelty or non-obviousness of the claims, especially if similar compounds or uses have been disclosed elsewhere.
- Infringement risk: The scope limits might influence the likelihood of infringement by competitors developing structurally similar compounds outside the defined claims.
Trends and future directions
- The landscape indicates a strategy of filing follow-up patents to expand coverage.
- Increasing focus on conjugates, prodrugs, and therapeutic combinations related to the core compound.
Summary of patent landscape
| Aspect |
Details |
| Focus |
Chemical compounds with therapeutic activity against specific biological targets |
| Assignee |
Major pharmaceutical company active in this therapeutic area |
| Overlapping patents |
Numerous filings targeting similar structures and uses |
| Geographic scope |
US, Europe, Asia, via PCT |
| Litigation risk |
Moderate, due to narrow claims and proliferation of similar patents |
Key Takeaways
- The patent protects a defined chemical class with specific therapeutic claims.
- The landscape involves multiple patents aiming to cover similar compounds and expanded indications.
- Broader patent coverage faces potential validity challenges based on prior art.
- The strategic filing of follow-up patents aims to fortify and extend intellectual property rights.
- Legal and infringement risks depend on the specificity of claims and the scope of competing patents.
FAQs
1. What specific diseases or conditions does the patent target?
The patent claims relate to indications associated with the biological target, including certain cancers or neurological disorders, depending on the precise chemical structure and use claims.
2. How broad are the chemical claims in the patent?
Claims are narrow, covering specific core structures with defined substituents. Variations outside these limits are not covered unless explicitly included in subsequent patents.
3. Can a competitor develop similar compounds outside the claim scope?
Yes. Due to the narrow claim language, competitors may develop similar compounds with different structural features or modifications not covered.
4. What is the status of patent enforceability?
The patent was granted in 2005. Enforceability depends on ongoing validity challenges, claim interpretation, and potential litigation involving overlapping patents.
5. How does this patent fit into the global IP strategy?
The patent forms part of a broader strategy that includes filings in multiple jurisdictions to maintain market exclusivity and mitigate patent clearance risks.
References
[1] United States Patent and Trademark Office. (2023). Patent number 6,933,395.
[2] Fish & Richardson. (2021). Patent landscape analysis for chemical compounds in pharmaceutical IP.
[3] European Patent Office. (2022). Patent applications related to chemical therapeutics.
